What we found on the web about Metformin
Metformin (INN; trade names Glucophage, Glucophage XR, Riomet, Fortamet, Glumetza, Obimet, Dianben, Diabex, Diaformin, and others) (pronounced /mɛtˈfɔrmɪn/) is an oral anti ...
Politor is the brand name of the Pioglitazone and Metformin combination preparation (Pioglitazone 15mg and Metformin 500mg tablet and Pioglitazone 15mg and Metformin 850mg tablet ...
Metformin, Glucophage and Glucovance, are type 2 medications which lower the livers glucose production as well as increasing insulin receptors on muscle and fat cells.
Metformin is one of the agents that we use to treat type 2 diabetes. It's actually one of the first agents that we might use, as long as you don't have any known side effects of ...
Metformin / Glucophage / Dianben / Metforal ... Overcome age-related diabetes with Metformin . Metformin regulates blood glucose levels to tackle age-related diabetes and lower ...
Metformin may rarely cause a serious, life-threatening condition called lactic acidosis. Tell your doctor if you have or have ever had a heart attack; stroke; high blood pressure ...
Metformin (Glucophage) is an oral medication that can help to stimulate ovulation in women with ovulation problems and polycystic ovarian syndrome, PCOS. Advanced Fertility Center ...
Canadian Brand Names: Alti-Metformin; Apo-Metformin®; Gen-Metformin; Glucophage®; Glycon; Novo-Metformin; Nu-Metformin; PMS-Metformin; Rho®-Metformin; Rhoxal-metformin FC
A popular oral drug for treating Type 2 diabetes. Metformin (brand name Glucophage) is a member of a class of drugs called biguanides that helps lower blood sugar levels by ...
Drug information about metformin (Glucophage, Glucophage XR, Glumetza, Fortamet, Riomet), a drug used for treating type II diabetes in adults and children.
Metformin was approved for use in the U.S. for treatment of type 2 diabetes in December, 1994. It is sold under the brand name Glucophage and is also available generically.
Metformin is a prescription medicine used to decrease blood sugar levels in people with type 2 diabetes. This eMedTV page explains how metformin works to decrease the amount of ...
Some of the most common metformin side effects can include indigestion, headache, and diarrhea. This eMedTV Web page also takes an in-depth look at some of the more serious ...
Here is what users have to say about Metformin

Metformin (INN; trade names Glucophage, Riomet, Fortamet, Glumetza, Obimet, Dianben, Diabex, Diaformin, and others) ( ) is an oral anti-diabetic drug from the biguanide class. It is the first-line drug for the treatment of type 2 diabetes, particularly in overweight and obese people and those with normal kidney function, and evidence suggests it may be the best choice for people with heart failure. It is also used in the treatment of polycystic ovary syndrome.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Metformin
Phramalive.com
Results from Roche's Phase III study T-EMERGE 2 met its primary endpoint of change in HbA1c (subcutaneous weekly taspoglutide versus subcutaneous twice-daily exenatide, as add-on to metformin, a thiazolidinedione [TZD], or metformin and a T...
ZDNet
Diabetes prevention costs a lot less than treatment, and much of the savings expected from health reform is based on studies like this which prove that prevention works.
Medical News Today
Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical group, announced that its partner Roche has disclosed the results of a first phase III clinical study using Taspoglutide, the first human once weekly glucagon-like pept...
Reuters
Diabetics in the study were also taking drugs to control their blood sugar, such as metformin, sulfonylureas and insulin. A study in rats last February by researchers at Northwestern University in Illinois suggested that insulin may shield ...
Honolulu Advertiser
A national 10-year study that included Hawaii participants reports that intensive lifestyle changes aimed at modest weight loss and increased physical activity reduced the rate of developing type 2 diabetes by 34 percent.
MSN Money
The study, which was supported by Novo Nordisk and Diabetes UK, was a three-year randomised, controlled, multicentre trial, in which 708 patients with suboptimal HbA1c levels on metformin and sulphonylurea therapy were assigned to receive N...
Kansas City InfoZine
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.